1 824 170 EFFECT OF YOGA ON GLYCEMIA AND LIPID PARAMETERS IN TYPE-2 DIABETES: A META-ANALYSIS. PURPOSE: PRIOR SYSTEMATIC REVIEWS ON YOGA AND DIABETES HAVE GIVEN CONFLICTING RESULTS. THEY HAVE BEEN LIMITED BY INCLUSION OF UNCONTROLLED UNBLINDED SINGLE GROUP OBSERVATIONAL STUDIES. NO REVIEWS ARE AVAILABLE WHICH HAVE USED THE COCHRANE METHODOLOGY AND GRADE (GRADES OF RECOMMENDATION, ASSESSMENT, DEVELOPMENT AND EVALUATION) APPROACH. THIS META-ANALYSIS EVALUATED THE EFFICACY OF YOGA ON GLYCAEMIA AND LIPIDS IN T2DM USING THE COCHRANE METHODOLOGY AND GRADE APPROACH. METHODS: MAJOR REPOSITORIES WERE SEARCHED TO PICK RANDOMIZED CONTROLLED TRIALS INVOLVING T2DM PATIENTS RECEIVING YOGA. PRIMARY OUTCOME WAS TO EVALUATE CHANGES IN FASTING PLASMA GLUCOSE (FPG) AND GLYCATED HAEMOGLOBIN (HBA1C). SECONDARY OUTCOMES WERE TO EVALUATE CHANGES IN POST-PRANDIAL PLASMA GLUCOSE (PPG), TOTAL CHOLESTEROL (TC), TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C). SUB-GROUP ANALYSIS INVOLVING PEOPLE UNDERGOING STRUCTURED EXERCISE REGIMEN (SER) VERSUS THOSE UNDERGOING STANDARD DIABETES CARE IN CONTROLS WAS DONE. RESULTS: DATA FROM 13 STUDIES INVOLVING 1440 PATIENTS WERE ANALYSED. COMPARED TO CONTROLS, INDIVIDUALS DOING YOGA HAD SIGNIFICANTLY LOWER FPG [MEAN DIFFERENCE (MD) -17.22 MG/DL (95% CI: -26.19 - -8.26 MG/DL); P < 0.01; CONSIDERABLE HETEROGENEITY (CH); LOW CERTAINTY OF EVIDENCE (LCE)], PPG [MD -27.77 MG/DL (95% CI: -35.73 - -19.81 MG/DL); P < 0.01; LOW HETEROGENEITY; MODERATE CERTAINTY OF EVIDENCE (MCE)], TC [MD -19.48 MG/DL (95% CI: -31.97 - -6.99 MG/DL); P < 0.01; CH; LCE], TRIGLYCERIDES [MD -12.99 MG/DL (95% CI: -23.74 - -2.25 MG/DL); P < 0.01; CH; LCE], LDL-C [MD -11.71 MG/DL (95% CI: -17.49 - -5.93 MG/DL); P < 0.01; I(2) = 69% CH; LCE] AND SIGNIFICANTLY HIGHER HDL-C [MD 4.58 MG/DL (95% CI: 3.98-5.18 MG/DL); P < 0.01; LOW HETEROGENEITY; MCE]. ON SUB-GROUP ANALYSIS, WHERE YOGA WAS COMPARED TO SER, FPG WAS SIGNIFICANTLY LOWER IN YOGA GROUP. CONCLUSION: YOGA IMPROVES GLYCAEMIA AND LIPID PARAMETERS IN T2DM WITH ADDITIONAL BENEFITS SEEN BOTH IN PEOPLE DOING/NOT DOING STRUCTURED EXERCISE. SUPPLEMENTARY INFORMATION: THE ONLINE VERSION CONTAINS SUPPLEMENTARY MATERIAL AVAILABLE AT 10.1007/S40200-021-00751-0. 2021 2 692 34 EFFECT OF COMMUNITY-BASED YOGA INTERVENTION ON OXIDATIVE STRESS AND GLYCEMIC PARAMETERS IN PREDIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO STUDY THE EFFECTIVENESS OF YOGA INTERVENTION ON OXIDATIVE STRESS, GLYCEMIC STATUS, BLOOD PRESSURE AND ANTHROPOMETRY IN PREDIABETES. DESIGN: RANDOMIZED-CONTROLLED TRIAL. PARTICIPANTS: TWENTY NINE PREDIABETES SUBJECTS AGED 30-75 YEARS. SETTING: YOGA WAS CONDUCTED AT 4 DIFFERENT COMMUNITY DIABETES CLINICS IN MANGALORE, INDIA. INTERVENTIONS: PARTICIPANTS WERE RANDOMIZED TO EITHER 3-MONTH YOGA OR WAIT-LIST CONTROL GROUPS. MAIN OUTCOME MEASURES: MALONDIALDEHYDE, GLUTATHIONE, VITAMIN C, VITAMIN E, SUPEROXIDE DISMUTASE, PLASMA GLUCOSE, GLYCATED HAEMOGLOBIN, BMI, WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO AND BLOOD PRESSURE. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN MALONDIALDEHYDE (P<0.001), RELATIVE TO THE CONTROL GROUP. IN COMPARISON WITH THE CONTROL, THERE WAS A SIGNIFICANT IMPROVEMENT IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE LEVELS AT FOLLOW-UP. NO SIGNIFICANT IMPROVEMENT IN GLYCATED HAEMOGLOBIN, WAIST-TO-HIP RATIO OR ANY OF THE ANTIOXIDANTS WAS OBSERVED. CONCLUSIONS: YOGA INTERVENTION MAY BE HELPFUL IN CONTROL OF OXIDATIVE STRESS IN PREDIABETES SUBJECTS. YOGA CAN ALSO BE BENEFICIAL IN REDUCTION IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE. EFFECT OF YOGA ON ANTIOXIDANT PARAMETERS WAS NOT EVIDENT IN THIS STUDY. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER TRIALS INVOLVING ACTIVE CONTROL GROUPS. 2013 3 1033 53 EFFECTS OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS. AIMS/INTRODUCTION: A META-ANALYSIS WAS CARRIED OUT TO EVALUATE THE EFFICACY OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: THE PUBMED, EMBASE AND COCHRANE DATABASES WERE SEARCHED TO OBTAIN ELIGIBLE RANDOMIZED CONTROLLED TRIALS. THE PRIMARY OUTCOME WAS FASTING BLOOD GLUCOSE, AND THE SECONDARY OUTCOMES INCLUDED GLYCOSYLATED HEMOGLOBIN A1C, TOTAL CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, TRIGLYCERIDE AND POSTPRANDIAL BLOOD GLUCOSE. WEIGHTED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED. THE I(2) STATISTIC REPRESENTED HETEROGENEITY. RESULTS: A TOTAL OF 12 RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 864 PATIENTS MET THE INCLUSION CRITERIA. THE POOLED WEIGHTED MEAN DIFFERENCES WERE -23.72 MG/DL (95% CI -37.78 TO -9.65; P = 0.001; I(2) = 82%) FOR FASTING BLOOD GLUCOSE AND -0.47% (95% CI -0.87 TO -0.07; P = 0.02; I(2) = 82%) FOR HEMOGLOBIN A1C. THE WEIGHTED MEAN DIFFERENCES WERE -17.38 MG/DL (95% CI -27.88 TO -6.89; P = 0.001; I(2) = 0%) FOR POSTPRANDIAL BLOOD GLUCOSE, -18.50 MG/DL (95% CI -29.88 TO -7.11; P = 0.001; I(2) = 75%) FOR TOTAL CHOLESTEROL, 4.30 MG/DL (95% CI 3.25 TO 5.36; P < 0.00001; I(2) = 10%) FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, -12.95 MG/DL (95% CI -18.84 TO -7.06; P < 0.0001; I(2) = 37%) FOR LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND -12.57 MG/DL (95% CI -29.91 TO 4.76; P = 0.16; I(2) = 48%) FOR TRIGLYCERIDES. CONCLUSIONS: THE AVAILABLE EVIDENCE SUGGESTS THAT YOGA BENEFITS ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS. HOWEVER, CONSIDERING THE LIMITED METHODOLOGY AND THE POTENTIAL HETEROGENEITY, FURTHER STUDIES ARE NECESSARY TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN TYPE 2 DIABETES MELLITUS PATIENTS. 2017 4 1374 46 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 5 2145 32 THE EFFECTS OF MINDFULNESS EATING AND YOGA EXERCISE ON BLOOD SUGAR LEVELS OF PREGNANT WOMEN WITH GESTATIONAL DIABETES MELLITUS. AIM: THIS RANDOMIZED CONTROLLED TRIAL WAS CARRIED OUT TO INVESTIGATE THE EFFECT OF MINDFULNESS EATING AND YOGA EXERCISE ON BLOOD SUGAR LEVELS AMONG PREGNANT THAI WOMEN WITH GDM. BACKGROUND: INTERVENTIONS PROMOTING ACHIEVEMENT OF GOOD GLYCEMIC CONTROL RESULT IN DESIRED PREGNANCY OUTCOMES. LITTLE IS KNOWN ABOUT THE HEALTH BENEFITS OF MINDFULNESS EATING AND YOGA EXERCISE ON BLOOD SUGAR LEVELS AMONG PREGNANT WITH GDM. METHODS: A RANDOMIZED CONTROLLED TRIAL WAS CARRIED OUT. MAIN OUTCOME MEASURES WERE CAPILLARY FASTING PLASMA GLUCOSE, 2-H POSTPRANDIAL BLOOD GLUCOSE, AND HEMOGLOBIN A1C. RESULTS: THE INTERVENTION GROUP SHOWED SIGNIFICANTLY REDUCED FASTING PLASMA GLUCOSE, 2-H POSTPRANDIAL BLOOD GLUCOSE, AND GLYCOSYLATED HEMOGLOBIN (HBA1C) IN THE INTERVENTION GROUP (P<0.05). CONCLUSIONS: MINDFULNESS EATING AND YOGA EXERCISE HAD HEALTH BENEFITS ON GLYCEMIC CONTROL IN PREGNANT WOMEN WITH GDM. IT SHOULD BE RECOMMENDED IN CLINICAL AND COMMUNITY HEALTH SERVICES. 2014 6 1924 43 ROLE OF YOGA FOR PATIENTS WITH TYPE II DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS. TO UNDERSTAND THE ROLE AND EFFICACY OF YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS, THIS META-ANALYSIS WAS CONDUCTED. ELECTRONIC DATA BASES SEARCHED WERE PUBMED/MEDLINE, PROQUEST, PSYCINFO, INDMED, CENTRAL, COCHRANE LIBRARY, CAMQUEST AND CAMBASE TILL DECEMBER 17, 2014. ELIGIBLE OUTCOMES WERE FASTING BLOOD SUGAR (FBS), POST PRANDIAL BLOOD SUGAR (PPBS) AND GLYCOSYLATED HAEMOGLOBIN (HBA1C). RANDOMIZED CONTROLLED TRIALS AND CONTROLLED TRIALS WERE ELIGIBLE. STUDIES FOCUSSING ONLY ON RELAXATION OR MEDITATION OR MULTIMODAL INTERVENTION WERE NOT INCLUDED. A TOTAL OF 17 RCTS WERE INCLUDED FOR REVIEW. DATA FROM RESEARCH ARTICLES ON PATIENTS, METHODS, INTERVENTIONS- CONTROL AND RESULTS WERE EXTRACTED. MEAN AND STANDARD DEVIATIONS WERE UTILIZED FOR CALCULATING STANDARDIZED MEAN DIFFERENCE WITH 95% CONFIDENCE INTERVAL. HETEROGENEITY WAS ASSESSED WITH THE HELP OF I(2) STATISTICS. CHI(2) WAS USED TO RULE OUT THE EFFECTS OF HETEROGENEITY DUE TO CHANCE ALONE. BENEFICIAL EFFECTS OF YOGA AS AN ADD-ON INTERVENTION TO STANDARD TREATMENT IN COMPARISON TO STANDARD TREATMENT WERE OBSERVED FOR FBS [STANDARDIZED MEAN DIFFERENCE (SMD) -1.40, 95%CI -1.90 TO -0.90, P<0.00001]; PPBS [SMD -0.91, 95%CI -1.34 TO -0.48, P<0.0001] AS WELL AS HBA1C [SMD -0.64, 95%CI -0.97 TO -0.30, P<0.0002]. BUT RISK OF BIAS WAS OVERALL HIGH FOR INCLUDED STUDIES. WITH THIS AVAILABLE EVIDENCE, YOGA CAN BE CONSIDERED AS ADD-ON INTERVENTION FOR MANAGEMENT OF DIABETES. 2016 7 1476 32 INTEGRATED YOGA AND NATUROPATHY MODULE IN MANAGEMENT OF METABOLIC SYNDROME: A CASE REPORT. A 50-YEAR-OLD MALE PARTICIPANT WITH SEDENTARY LIFESTYLE, DIAGNOSED WITH METABOLIC SYNDROME (METS) [OBESITY, TYPE-2 DIABETES MELLITUS, HYPERTENSION] AND HYPOTHYROIDISM SINCE 2013, WAS ADMINISTERED INTEGRATED YOGA AND NATUROPATHY (IYN) FOR 6 WEEKS AS A TAILOR MADE INDIVIDUALIZED PROTOCOL AT THE RESIDENTIAL INTEGRATIVE MEDICAL FACILITY IN BANGALORE BETWEEN OCTOBER AND NOVEMBER 2015. THE RESULTS SHOWED REDUCTION IN WEIGHT (97.9 KG TO 74.6 KG), BODY MASS INDEX (BMI) (35.1 KG/M(2) TO 27.86 KG/M(2)), TOTAL CHOLESTEROL (192 MG% TO 145 MG%), TRIGLYCERIDES (153 MG% TO 90 MG%), LOW DENSITY LIPOPROTEIN (LDL) (124 MG% TO 81 MG%), HIGH DENSITY LIPOPROTEIN (HDL) (40 MG% TO 46 MG%), FASTING BLOOD GLUCOSE (110 MG/DL TO 75 MG/DL), POSTPRANDIAL GLUCOSE (267 MG/DL TO 100 MG/DL), GLYCATED HEMOGLOBIN (HBA1C) (7.8%-7.1%), THYROID STIMULATING HORMONE (TSH) (6.90 MUIU/ML TO 3.052 MUIU/ML). FOLLOWING THE INTERVENTION, THE ANTI-HYPERTENSIVE, ORAL HYPOGLYCEMIC, THYROID RAISING AND ANALGESIC MEDICINES WERE NOT REQUIRED TO BE CONTINUED. HIS KNEE PAIN MINIMIZED ON DISCHARGE AS OBSERVED ON A VISUAL ANALOG SCALE. HE HAD AN IMPROVED FEELING OF WELLNESS AND OVERALL FUNCTIONAL HEALTH. ALL HIS PARAMETERS WERE WITHIN NORMAL RANGE AT THE 12-WEEKS FOLLOW-UP, AS HE HAD INCORPORATED THE LIFESTYLE PROGRAM INTO HIS DAILY ROUTINE. THIS CASE REPORT SUGGESTS THAT LIFESTYLE CHANGE BY INTEGRATION OF SPECIFIC NON-DRUG YOGA AND NATUROPATHIC INTERVENTION IS USEFUL IN THE MANAGEMENT OF METS. 2017 8 1925 24 ROLE OF YOGA IN ALIENATING THE MEMORY DECLINE AND FRONTAL LOBE METABOLITE CHANGES IN TYPE 2 DIABETES. RECENT RESEARCH STUDIES HAVE ESTABLISHED THE FACT, THAT GLYCOSYLATION IS CAUSING THE MEMORY DECLINE AND THIS IS FURTHER SUPPORTED BY THE ALTERATION OF BRAIN METABOLITE CONCENTRATIONS IN DIABETES. THE PRESENT STUDY IS HYPOTHESIZED THAT YOGA IS HAVING ALIENATING ABILITY OF MEMORY DECLINE AND ALTERATION OF FRONTAL LOBE METABOLITE CONCENTRATIONS, WHICH ARE THE RESULT OF GLYCOSYLATION IN TYPE 2 DIABETES. FIVE TYPE 2 DIABETIC SUBJECTS OF BOTH THE SEX, AGED BETWEEN 35-55 YEARS, WHO PRACTICED YOGA OVER A PERIOD OF SIX MONTHS IN A YOGA INSTITUTE, WERE RECRUITED AS TEST GROUP. AGE AND SEX MATCHED FIVE TYPE 2 DIABETIC SUBJECTS WERE RECRUITED AS CONTROL GROUP, BOTH THE GROUP SUBJECTS ARE ON ORAL HYPOGLYCAEMIC AGENTS. GLYCOSYLATED HAEMOGLOBIN PERCENTAGE WAS ESTIMATED WITH BIO-RAD INSTRUMENT, FRONTAL LOBE METABOLITES WERE ESTIMATED WITH PROTON MAGNETIC RESONANCE SPECTROSCOPY (H-MRS), MEMORY WAS CALCULATED WITH PGI-MEMORY SCALE (PGIMS) THAT IS A PART OF PGI-BATTERY OF BRAIN DYSFUNCTION (PGI-BBD), WHICH IS A NEUROPSYCHOLOGICAL BATTERY. MEAN GLYCOSYLATED HAEMOGLOBIN PERCENTAGE AND MEMORY DYSFUNCTION RATING IN CONTROL AND TEST GROUP SUBJECTS ARE 6.9+/-0.4 & 7.8+/-1.84 (P=0.03), AND 14+/-1& 6+/-1 (P=0.0001) RESPECTIVELY. RIGHT AND LEFT FRONTAL LOBE N-ACETYL ASPARTATE (NAA) AND MYOIONOSITOL (MI) CONCENTRATIONS WERE MORE OR LESS SIMILAR IN BOTH THE GROUPS. YOGA IS HAVING A SIGNIFICANT ROLE IN ALIENATING THE DECLINE IN MEMORY CAUSED BY GLYCOSYLATION IN TYPE 2 DIABETES BUT NOT ON THE ALTERATION OF FRONTAL LOBE NAA AND MI CONCENTRATIONS. 2016 9 823 41 EFFECT OF YOGA ON GLUCOSE CONTROL AND QUALITY OF LIFE IN PATIENTS OF PREDIABETES. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE EFFECT OF YOGA ON FASTING PLASMA GLUCOSE (FPG), POSTPRANDIAL PLASMA GLUCOSE, AND HEMOGLOBIN A1C (HBA1C) AND ALSO ON QUALITY OF LIFE (QOL). RESEARCH DESIGN AND METHODS: THIS WAS A COHORT STUDY IN WHICH 100 DIAGNOSED CASES OF PREDIABETES WERE RECRUITED FOR DOING SPECIFIC YOGA, AND THEY THEMSELVES ACT AS CONTROL FOR THE STUDY. THE MEASUREMENT AND COMPARISON OF FPG, PRANDIAL PLASMA GLUCOSE (PPG), AND HBA1C WERE DONE AT THREE DIFFERENT TIME INTERVALS, THAT IS, BASELINE, 3 MONTHS, AND AT 6 MONTHS. THE ASSESSMENT OF QOL WAS DONE USING SF-36 SCALE. RESULTS: ONE HUNDRED PREDIABETIC CASES WERE SELECTED FOR THE STUDY IN WHICH IMPAIRED FASTING GLUCOSE (IFG) WAS PRESENT MORE IN YOUNGER POPULATION COMPARED TO IMPAIRED GLUCOSE TOLERANCE (IGT) AND IFG PLUS IGT BOTH OF WHICH ARE MORE PREVALENT IN MIDDLE AGE GROUP. THE YOGA THERAPY WAS FOUND TO HAVE FAVORABLE EFFECT ON FPG, PPG, AND HBA1C ALONG WITH VARIOUS ANTHROPOMETRY MEASURES STUDIED IN THIS STUDY. AFTER ADJUSTING CORRELATION COEFFICIENT FOR VARIOUS ANTHROPOMETRY MEASURES, YOGA WAS FOUND TO BE EFFECTIVE FOR CONTROLLING GLYCEMIC PARAMETERS IN PREDIABETICS. CONCLUSIONS: YOGA IS A TYPE OF EXERCISE KNOWN TO IMPROVE GLYCEMIC CONTROL BY CHANGING ANTHROPOMETRY MEASURES, BUT OUR STUDY AIDS IN KNOWLEDGE ABOUT THE BENEFICIAL EFFECT BEYOND THIS KNOWN FACT THROUGH OTHER MECHANISMS YET TO BE EXPLORED. 2021 10 1104 33 EFFECTS OF YOGA VERSUS SHAM YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS: A SINGLE-BLINDED RANDOMIZED PILOT STUDY. STUDIES HAVE SHOWN A BENEFICIAL ROLE OF YOGA IN TRE A T I N G TYPE 2 DIABETES MELLITUS. THE PRESENT STUDY PROCEEDS IN THE FIELD BY PROVIDING AN ACTIVE CONTROL. WE AIMED TO EVALUATE THE EFFECT OF 3 MONTHS OF YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. FORTY PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER YOGA (N = 20) OR SHAM YOGA (N = 20) AS A CONTROL. YOGA INCLUDED POSTURES AND BREATHING EXERCISES, AND NONAEROBIC STRETCHING EXERCISE COMPRISED THE CONTROL. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN MALONDIALDEHYDE, VITAMIN C, SUPEROXIDE DISMUTASE, FASTING BLOOD GLUCOSE, GLYCOSYLATED HEMOGLOBIN, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND BLOOD PRESSURE WERE EVIDENT IN BOTH GROUPS. YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER IMPROVEMENT IN REDUCED GLUTATHIONE COMPARED TO CONTROLS. NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN ANY OTHER OUTCOME VARIABLES. YOGA AND SHAM YOGA HAD IDENTICAL EFFECTS ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. LEVELS OF REDUCED GLUTATHIONE IMPROVED ONLY IN THE YOGA GROUP. THIS RESEARCH NEEDS TO BE CONFIRMED BY LARGER AND SUFFICIENTLY POWERED STUDIES. 2020 11 178 40 A RANDOMIZED CONTROLLED TRIAL OF THE EFFECT OF YOGA AND PEER SUPPORT ON GLYCAEMIC OUTCOMES IN WOMEN WITH TYPE 2 DIABETES MELLITUS: A FEASIBILITY STUDY. BACKGROUND: TYPE TWO DIABETES IS A COMPLEX AND DEMANDING CHRONIC DISEASE AND ITS IMPACT IN A STATE (KERALA) WHICH LEADS INDIA IN TERMS OF THE NUMBER OF PEOPLE WITH DIABETES IS PROFOUND. THOUGH THE MALE TO FEMALE RATIO AMONG THE PEOPLE WITH DIABETES IS ROUGHLY EQUAL, WOMEN ARE UNIQUELY AND MORE SEVERELY AFFECTED. MANAGEMENT OF TYPE TWO DIABETES REQUIRES CONSIDERABLE DEXTERITY ON THE PART OF THE PATIENT TO MANAGE DRUGS, DIET AND EXERCISE. THEREFORE, IN A LOW MIDDLE-INCOME COUNTRY LIKE INDIA IT IS NECESSARY TO LOOK AT LOW COST INTERVENTIONS THAT CAN EMPOWER THE PATIENT AND BUILD ON AVAILABLE RESOURCES TO HELP MANAGE DIABETES. HENCE, WE STUDIED THE FEASIBILITY AND EFFECT OF TWO LOW COST INTERVENTIONS; YOGA AND PEER SUPPORT ON GLYCAEMIC AND OTHER OUTCOMES AMONG WOMEN WITH TYPE TWO DIABETES. METHODS: AN OPEN LABEL PARALLEL THREE ARMED RANDOMIZED CONTROL TRIAL WAS CONDUCTED AMONG 124 RECRUITED WOMEN WITH DIABETES FOR THREE MONTHS. BLOCK RANDOMIZATION WITH A BLOCK LENGTH OF SIX WAS CARRIED OUT WITH EACH GROUP HAVING AT LEAST 41 WOMEN. IN THE YOGA ARM, SESSIONS BY AN INSTRUCTOR, CONSISTING OF A GROUP OF POSTURES COORDINATED WITH BREATHING WERE CONDUCTED FOR AN HOUR, TWO DAYS A WEEK. IN THE PEER SUPPORT ARM EACH PEER MENTOR AFTER TRAINING VISITED 13-14 WOMEN WITH DIABETES EVERY WEEK FOLLOWED BY A PHONE CALL. THE MEETING WAS ABOUT APPLYING DISEASE MANAGEMENT OR PREVENTION PLANS IN DAILY LIFE. RESULTS: THERE WAS A TREND IN DECLINE OF FASTING PLASMA GLUCOSE IN THE PEER AND YOGA GROUP AND OF GLYCOSYLATED HAEMOGLOBIN (HBA1C) IN THE YOGA GROUP ONLY, THOUGH NOT SIGNIFICANT. A SIGNIFICANT DECREASE WAS OBSERVED IN DIASTOLIC BLOOD PRESSURE AND HIP CIRCUMFERENCE IN THE YOGA GROUP. THE PROCESS INDICATED THAT MOST (80%) OF THE WOMEN IN THE YOGA GROUP ATTENDED CLASSES REGULARLY AND 90% OF THE WOMEN IN THE PEER GROUP REPORTED THAT PEER MENTORING WAS USEFUL. CONCLUSION: THE EFFECT OF YOGA AND PEER SUPPORT ON GLYCAEMIC OUTCOMES WAS INCREMENTAL. LONGER TERM STUDIES ARE NECESSARY TO ASCERTAIN THE BENEFITS SHOWN BY THIS FEASIBILITY STUDY. TRIAL REGISTRATION: CTRI/2011/12/002227 DATED 14/12/2011. 2017 12 1366 36 IMPACT OF A 10 MINUTE SEATED YOGA PRACTICE IN THE MANAGEMENT OF DIABETES. OBJECTIVE: WE SOUGHT TO PROSPECTIVELY EVALUATE THE IMPACT OF A 10 MINUTE SEATED YOGA PROGRAM ADDED TO STANDARD COMPREHENSIVE DIABETES CARE ON GLUCOSE CONTROL AND CARDIOVASCULAR HEALTH IN THE SEVERELY ILL, MEDICALLY COMPLEX DIABETIC POPULATION. METHOD: A TOTAL OF 10 PATIENTS WITH TYPE 2 DIABETES, AGES 49-77, WITH DURATION OF DIABETES >10 YEARS AND HAEMOGLOBIN A1C >9% (75 MMOL/MOL) WERE INCLUDED IN THE STUDY. PATIENTS RANDOMIZED TO A YOGA INTERVENTION WERE TAUGHT A 10 MINUTE SEATED YOGA PRACTICE, WERE GIVEN AN EXPLANATORY DVD AND A FOLD-OUT POCKET GUIDE TO ENCOURAGE ADHERENCE AT HOME, AND WERE INSTRUCTED TO INCORPORATE THE PRACTICE AS OFTEN AS THEY COULD. THE PATIENTS IN THE CONTROL ARM WERE PROVIDED INFORMATION AND HAND OUTS ON THE AVAILABLE YOGA CLASSES ON CAMPUS. RESULTS: AT 3 MONTH CLINICAL FOLLOW UP, THE MEAN DECREASE IN FASTING CAPILLARY BLOOD GLUCOSE (CBG) WAS 45% AMONG YOGA PARTICIPANTS (-5.2 +/- 4.1 MMOL/L). HEART RATE (HR) DROPPED BY 18% AND DIASTOLIC BLOOD PRESSURE (BP) DROPPED BY 29% IN THE INTERVENTION ARM, (-12.4 +/- 6.69 AND -26 +/- 12.05 MMHG, RESPECTIVELY). THERE WERE NO STATISTICALLY SIGNIFICANT CHANGES IN THE HAEMOGLOBIN A1C, SYSTOLIC BLOOD PRESSURE, WEIGHT, OR BODY MASS INDEX IN EITHER GROUP. CONCLUSION: OUR SMALL PILOT STUDY REINFORCES THE CURRENT MEDICAL EVIDENCE SUPPORTING THE USE OF YOGA, COMBINED WITH STANDARD CARE, TO IMPROVE HEALTH OUTCOMES IN DIABETES. 2016 13 138 29 A PRELIMINARY REPORT ON THE ROLE OF YOGA ASANAS ON OXIDATIVE STRESS IN NON-INSULIN DEPENDENT DIABETES MELLITUS. NINETEEN SUBJECTS OF NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) BETWEEN THE AGE GROUP OF 30-60 YRS WERE STUDIED TO SEE THE EFFECT OF SPECIFIC YOGA ASANAS ON FASTING AND POSTPRANDIAL BLOOD GLUCOSE (FBG, PPG), SERUM MALONDIALDEHYDE (MDA) AND GLYCOSYLATED HEMOGLOBIN (HBA(1)) IN ADDITION TO DRUG TREATMENT AND DIET CONTROL. THE DURATION OF DIABETES RANGED FROM 1-10 YEARS. PATIENTS WITH RENAL, CARDIAC AND PROLIFERATIVE RETINAL DISEASES WERE EXCLUDED FROM THE STUDY. THE SAME PATIENTS SERVED AS THEIR OWN CONTROL. SUBJECTS WERE CALLED IN THE MORNING TO THE CARDIO-RESPIRATORY LABORATORY AND WERE GIVEN TRAINING BY A YOGA EXPERT. YOGA ASANAS INCLUDED SURYANAMSKAR, TADASAN, TRIKONASAN, PADMASAN, PRANAYAM, PASCHIMOTTANASAN, ARDHMATSYENDRASAN, PAVANMUKTHASAN, SARPASAN AND SHAVASAN. THE ASANAS WERE DONE EVERY DAY FOR 40 DAYS FOR 30-40 MIN. FBG, PPG, SERUM MDA AND HBA(1) WERE ESTIMATED BEFORE AND AFTER 40 DAYS OF YOGA ASANAS REGIMEN. SIGNIFICANT REDUCTION WAS SEEN IN FBG FROM 220 MG/DL TO 162 MG/DL, PPG FROM 311 MG/DL TO 255 MG/DL, MDA FROM 6 NMOL/L TO 3 NMOL/L AND HBA(1), FROM 8.8% TO 6.4%. SUBJECTS FELT BETTER AND WERE RELIEVED OF THEIR STRESSES AND HAD AN IMPROVEMENT IN THEIR DAY TO DAY PERFORMANCE. THE DECREASE WAS STATISTICALLY SIGNIFICANT (P<0.0001 FOR FBG AND PPG, P<0.001 FOR MDA AND FOR HBA(1)). 2001 14 1458 20 INFLUENCE OF YOGA ON BLOOD COAGULATION. YOGA IS KNOWN TO INDUCE BENEFICIAL EFFECTS ON PHYSIOLOGICAL, BIOCHEMICAL AND MENTAL FUNCTIONS IN MAN. ITS EFFECTS ON BLOOD COAGULATION ARE NOT KNOWN. A STUDY WAS CONDUCTED IN SEVEN PREVIOUSLY UNTRAINED MALE ADULTS WHO UNDERWENT A COMBINATION OF YOGIC EXERCISES, DAILY FOR ONE HOUR, OVER A PERIOD OF FOUR MONTHS. PARAMETERS OF BLOOD COAGULATION WERE ESTIMATED BEFORE AND AFTER THE END OF YOGA TRAINING. THE FOLLOWING CHANGES WERE OBSERVED: FIBRINOLYTIC ACTIVITY INCREASED SIGNIFICANTLY WITH A CONCOMITANT FALL IN FIBRINOGEN; ACTIVATED PARTIAL THROMBOPLASTIN TIME AND PLATELET AGGREGATION TIME WERE PROLONGED; BLOOD AND PLASMA PLATELETS SHOWED A RISE; AND BOTH HAEMOGLOBIN AND HEAMATOCRIT WERE RAISED AT THE END OF THE TRAINING. THESE FINDINGS SUGGEST THAT YOGA INDUCES A STATE OF BLOOD HYPOCOAGULABILITY. THE IMPACT OF YOGA ON PREVENTION OF CARDIOVASCULAR AND THROMBOTIC DISORDERS IS OBVIOUS. 1984 15 1116 39 EFFICACY OF A VALIDATED YOGA PROTOCOL ON DYSLIPIDEMIA IN DIABETES PATIENTS: NMB-2017 INDIA TRIAL. BACKGROUND: DYSLIPIDEMIA IS CONSIDERED A RISK FACTOR IN TYPE 2 DIABETES MELLITUS (T2DM) RESULTING IN CARDIO-VASCULAR COMPLICATIONS. YOGA PRACTICES HAVE SHOWN PROMISING RESULTS IN ALLEVIATING TYPE 2 DIABETES PATHOLOGY. METHOD: IN THIS STRATIFIED TRIAL ON A YOGA BASED LIFESTYLE PROGRAM IN CASES WITH TYPE 2 DIABETES, IN THE RURAL AND URBAN POPULATION FROM ALL ZONES OF INDIA, A TOTAL OF 17,012 ADULTS (>20 YEARS) OF BOTH GENDERS WERE SCREENED FOR LIPID PROFILE AND SUGAR LEVELS. THOSE WHO SATISFIED THE SELECTION CRITERIA WERE TAUGHT THE DIABETES YOGA PROTOCOL (DYP) FOR THREE MONTHS AND THE DATA WERE ANALYZED. RESULTS: AMONG THOSE WITH DIABETES, 29.1% HAD ELEVATED TOTAL CHOLESTEROL (TC > 200 MG/DL) LEVELS THAT WERE HIGHER IN URBAN (69%) THAN RURAL (31%) DIABETES PATIENTS. THERE WAS A POSITIVE CORRELATION (P = 0.048) BETWEEN HBA1C AND TOTAL CHOLESTEROL LEVELS. DYP INTERVENTION HELPED IN REDUCING TC FROM 232.34 +/- 31.48 MG/DL TO 189.38 +/- 40.23 MG/DL WITH SIGNIFICANT PRE POST DIFFERENCE (P < 0.001). CONVERSION RATE FROM HIGH TC (>200 MG/DL) TO NORMAL TC (<200 MG/DL) WAS OBSERVED IN 60.3% OF CASES WITH TYPE 2 DIABETES MELLITUS (T2DM); FROM HIGH LDL (>130 MG/DL) TO NORMAL LDL (<130 MG/DL) IN 73.7%; FROM HIGH TRIGLYCERIDE (>200 MG/DL) TO NORMAL TRIGLYCERIDE LEVEL (<200 MG/DL) IN 63%; FROM LOW HDL (<45 MG/DL) TO NORMAL HDL (>45 MG/DL) IN 43.7% OF T2DM PATIENTS AFTER THREE MONTHS OF DYP. CONCLUSIONS: A YOGA LIFESTYLE PROGRAM DESIGNED SPECIFICALLY TO MANAGE DIABETES HELPS IN REDUCING THE CO-MORBIDITY OF DYSLIPIDEMIA IN CASES OF PATIENTS WITH T2DM. 2019 16 497 35 COMBINED AYURVEDA AND YOGA PRACTICES FOR NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS: A CONTROLLED TRIAL. BACKGROUND: THE INCREASING PREVALENCE OF TYPE 2 DIABETES IN INDIA IS A CAUSE FOR NATIONAL CONCERN, PARTICULARLY THE SPIRALING COST BURDEN TO THE COUNTRY. AS ONE APPROACH TO STOP ITS INCREASE, YOGA MEDICINE HAS BEEN WIDELY IMPLEMENTED, FINDING POPULARITY WITH ALL SOCIAL STRATA. HERE, WE REPORT A STUDY SUGGESTING THAT TREATMENT WITH FRESH HERBAL JUICES AND YOGA CAN IMPROVE THE LEVELS OF BLOOD GLUCOSE AND HEMOGLOBIN A1C (HBA1C) IN PEOPLE WITH PRE-DIABETES. METHODS: STUDY DESIGN: 3-ARM CONTROLLED TRIAL 3 MONTHS IN DURATION. PARTICIPANTS: 157 MALE PRISONERS WITH NEWLY DIAGNOSED, HIGH FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS. GROUP INTERVENTIONS: (1) RASAHARA AND YOGA, (2) YOGA, (3) NO INTERVENTION. ASSESSMENTS: FBS AND PPBS LEVELS WERE MEASURED EVERY 2 WEEKS; HBA1C AND BLOOD LIPIDS WERE DETERMINED PRE- AND POST-INTERVENTION. RESULTS: SIGNIFICANT DECREASES OCCURRED IN THE FBS (-21.13 +/- 21.16 MG/DL) AND PPBS LEVELS (-15.02 +/- 14.89 MG/DL) IN GROUP 1 (BOTH P < 0.0001) AND IN THE FBS LEVEL (20.62 +/- 32.68 MG/DL) IN GROUP 2 (P = 0.0005), WHILE THE INCREASES IN GROUP 3 ATTAINED SIGNIFICANCE ONLY FOR THE PPBS LEVEL (9.62 +/- 21.83 MG/DL) (P = 0.0022). OBSERVED CHANGES IN HBA1C WERE: GROUP 1, -0.044 +/- 0.059 MG/DL; GROUP 2, +0.024 +/- 0.456 MG/DL (NOT SIGNIFICANT); AND GROUP 3, +0.365 +/- 0.369 MG/DL (P < 0.0001). CONCLUSIONS: THIS STUDY OF YOGA FOR THE TREATMENT OF DIABETES SHOWS THAT ALL MALE PRISONERS COULD BENEFIT FROM THE YOGA PRISON PROGRAMS. ADDITION OF YOGA PROGRAMS TO STATE AND FEDERAL ACTIVITIES AT ALL LEVELS IS NOW NATIONAL POLICY IN INDIA. FOLLOW-UP STUDIES SHOULD BE CARRIED OUT TO OBTAIN MORE ROBUST RESULTS. 2018 17 1453 30 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 18 959 29 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 19 691 50 EFFECT OF COMMUNITY-BASED STRUCTURED YOGA PROGRAM ON HBA1C LEVEL AMONG TYPE 2 DIABETES MELLITUS PATIENTS: AN INTERVENTIONAL STUDY. CONTEXT: IN VIEW OF THE RISING BURDEN OF TYPE 2 DIABETES MELLITUS (DM) CASES IN INDIA, THERE IS AN URGENT NEED FOR AN EFFECTIVE, LOW-COST, SUSTAINABLE INTERVENTION CONTROLLING DIABETES THUS PREVENTING COMPLICATIONS. AIMS: THIS STUDY AIMED TO ASSESS THE EFFECT OF STRUCTURED YOGA PROGRAMS ON DIABETES. SUBJECTS AND METHODS: THIS WAS A COMMUNITY-BASED INTERVENTIONAL STUDY THAT WAS CONDUCTED IN AN URBAN RESETTLEMENT COLONY OF DELHI, INDIA. KNOWN DIABETES PATIENTS WITH GLYCATED HEMOGLOBIN (HB1AC) >/=6.5% WERE ENROLLED FROM 12 RANDOMLY SELECTED BLOCKS OF THE COMMUNITY WITH A SAMPLE SIZE OF 192 IN EACH INTERVENTION AND WAIT-LISTED CONTROL ARM. THE INTERVENTION WAS STRUCTURED YOGA OF 50 MIN DAILY, 2 CONSECUTIVE WEEKS IN A NEARBY PARK AND HEALTH CENTER FOLLOWED BY TWICE A WEEK HOME PRACTICE UP TO THE 3(RD) MONTH. THE PRIMARY OUTCOME MEASURE WAS HBA1C% AND SECONDARY OUTCOME MEASURES WERE LIPID PROFILE AND FASTING BLOOD GLUCOSE. STATISTICAL ANALYSIS USED: APER-PROTOCOL ANALYSIS WAS DONE. MEAN, STANDARD DEVIATION (SD), AND 95% CONFIDENCE INTERVAL WERE ESTIMATED. THE LEVEL OF SIGNIFICANCE WAS CONSIDERED FOR 0.05. RESULTS: THERE WAS A SIGNIFICANT DECREASE OF HB1AC (0.5%, SD = 1.5, P = 0.02), TOTAL CHOLESTEROL (11.7 MG/DL, SD = 40.5, P < 0.01), AND LOW-DENSITY LIPOPROTEIN (3.2 MG/DL, SD = 37.4, P < 0.01) FROM BASELINE TO END LINE IN THE INTERVENTION GROUP. THESE CHANGES IN INTERVENTION GROUP WERE ALSO SIGNIFICANTLY DIFFERENT FROM THE CHANGE IN THE WAIT-LISTED CONTROL GROUP. THE OTHER VARIABLES DID NOT CHANGE SIGNIFICANTLY. CONCLUSIONS: IT REVEALED THAT STRUCTURED YOGA PROGRAM IMPROVED GLYCEMIC OUTCOME AND LIPID PROFILE OF INDIVIDUALS IN A COMMUNITY-BASED SETTING. YOGA CAN BE A FEASIBLE STRATEGY TO CONTROL HYPERGLYCEMIA, LIPID LEVELS, AND CAN HELP BETTER CONTROL TYPE 2 DM. 2021 20 685 39 EFFECT OF AN INTEGRATED NATUROPATHY AND YOGA PROGRAM ON LONG-TERM GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE COHORT STUDY. AIM: LIFESTYLE IS AN IMPORTANT RISK FACTOR FOR INCREASING THE PREVALENCE OF DIABETES IN THE INDIAN POPULATION. IN THIS STUDY, WE EVALUATE THE EFFECTS OF NATUROPATHY TREATMENT, SALT-RESTRICTED LOW-CALORIE DIETS, AND YOGA IN LONG-TERM GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: IN THIS PROSPECTIVE, LONGITUDINAL, TWO-ARM COHORT STUDY, PATIENTS WITH TYPE 2 DIABETES MELLITUS REFERRED FROM A TERTIARY CARE CENTER UNDERGOING A 3-MONTH RESIDENTIAL NATUROPATHY TREATMENT WERE COMPARED WITH THOSE UNDERGOING ONLY CONVENTIONAL MANAGEMENT ON GLYCEMIC CONTROL. BOTH FASTING AND POSTPRANDIAL BLOOD GLUCOSE (PPBG) LEVELS WERE ASSESSED AT BASELINE, 3 MONTHS FOLLOWING INTERVENTION, AT 6 MONTHS, AND 12 MONTHS FROM THE STUDY START. DATA WERE ANALYZED USING REPEATED-MEASURES ANOVA WITH POST HOC BONFERRONI CORRECTION. RESULTS: NATUROPATHY AND YOGA INTERVENTION SIGNIFICANTLY REDUCED PPBG LEVELS (P < 0.001), GLYCATED HEMOGLOBIN LEVELS (P < 0.001), AND REDUCED REQUIREMENT FOR ANTIDIABETIC MEDICATIONS (P < 0.008) IN THE INTERVENTION GROUP COMPARED TO CONTROLS. THE EFFECTS WERE MORE PROFOUND IMMEDIATELY FOLLOWING INTERVENTION AND LASTED UP TO 6 MONTHS FROM THE START OF THE STUDY. CONCLUSION: THE RESULTS SUGGEST BENEFIT WITH AN INTENSIVE RESIDENTIAL NATUROPATHY-BASED LIFESTYLE INTERVENTION PROGRAM. RANDOMIZED CONTROLLED TRIALS ARE NEEDED TO FURTHER VALIDATE THE FINDINGS. 2020